Posts tagged “Merck”

June 30, 2011

Premium Lock Merck to close former Inspire HQ in Raleigh, cut 51 workers

Merck  The drug giant recently purchased Raleigh-based Inspire Pharmaceuticals. In a notice filed with the state, the expected closure of Inspire's offices is made official.

May 17, 2011

Premium Lock Merck wraps up $430M Inspire deal, will close Raleigh HQ

Merck  Some company executives will be leaving the eye drug firm as it is absorbed by the pharmaceutical giant.

November 30, 2010

Premium Lock Merck names its president to replace CEO

Merck  Richard Clark will remain chairman of the drug giant when Kenneth Frazier assumes CEO role. Merck operates a vaccine manufacturing plant in Durham.

November 29, 2010

Premium Lock GSK drug reduces prostate cancer risk, FDA panel says

Prostate cancer Merck drug also receives support, but reviewers express concern about the overall benefits of the drugs.

November 17, 2010

Premium Lock Next big thing? Big cholesterol drop with new drug

Merck  An experimental Merck drug safely boosted good cholesterol to record highs while dropping bad cholesterol to unprecedented lows in a study that stunned researchers and renewed hopes for an entirely new way of lowering heart risks.

May 4, 2010

Premium Lock Rx for $$$: Pfizer, Merck report strong quarterly sales results

Merck, Pfizer report financials The drug giants, which are growing their presence in the Research Triangle region, say first-quarter sales were strong. Wyeth acquisition boosts Pfizer. But Schering-Plough acquisition costs hurt Merck profits.

Updated November 4, 2009

Premium Lock Merck swallows Schering-Plough and becomes No. 2

Merck merger The two pharma giants completed the deal after the markets closed Tuesday, and the new Merck moved up from being the No. 8 drugmaker. creating the No. 2 drug-maker

July 22, 2009

Premium Lock Wyeth plant in Sanford closer to new ownership by Pfizer

Pfizer Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.

Updated July 9, 2009

Premium Lock World Health Organization approves GSK cervical cancer vaccine

GSK Cervarix could save 'millions of women's lives throughout the world,' GSK exec says. Drug giant is seeking FDA approval in U.S.

Updated June 6, 2009

Premium Lock New study backs diabetes drug Avandia, GSK says

GSK Drug giant releases results of its own study at diabetes conferencing that it says downplays heart attack risks. WHO, meanwhile, endorses GSK diarrhea drug.

Updated June 3, 2009

Premium Lock FTC clears GSK's $3B buyout of Stiefel Labs

GSK growing larger Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.

Updated May 22, 2009

Premium Lock Triangle region beat 100,000 new jobs goal, partnership says; more coming?

Charles Hayes Looking ahead, leaders of 13-county Research Triangle Regional Partnership outline new five-year plan for "Staying on Top." Recruiting pipeline is strong, RTRP’s top exec says. Since 2003, employment grew in all the region’s 13 counties but Warren, which lost 407 jobs.

Tags: IBM, Merck
Updated May 21, 2009

Premium Lock Want some good news? New report rates Triangle fifth among 11 top metros for biotech

Triangle ranks 5th in new Milken Institute study Milken Institute ranks RTP second for innovation as well as research and development. However, lack of 'risk capital' and entrepreneurship helps drag down its overall score.

Tags: GSK, Merck
Updated April 22, 2009

Premium Lock After profit drops, GSK CEO says U.S. operations face more changes

GSK 'It is essential that we reconfigure our U.S. business to make sure we have the right resource in the right areas and an overall lower level of infrastructure costs,' Andrew Witty says.

Updated April 17, 2009

Premium Lock New giant with Triangle roots to combat HIV - GSK, Pfizer form joint venture

Dominique Limet As yet unnamed company will based U.S. operations in RTP where GSK has a long history of AIDS research. Venture will be No. 2 in HIV drug market share from launch.

Updated March 18, 2009

Premium Lock NCRC: Merck vice president to head Murdock Research Institute

 North Carolina native to help coordinate research efforts at N.C. Research Institute.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith